GA
GWPH

Geneva Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Geneva Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,485
Closed -$696K – 740
2014
Q2 		$696K Buy
+6,485
New +$451K 0.01% 378

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Geneva Advisors's GWPH Position: Q3 2014 in Review

Geneva Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2014, closing a stake of 6,485 shares — an estimated $696K sold.

Geneva Advisors first reported a position in GWPH in Q2 2014 and held it in 1 quarter. The position peaked at $696K in Q2 2014. 87 funds tracked by Wall St. Rank hold GWPH as of Q3 2014.

  • Geneva Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2014 after selling out during the quarter.
  • Geneva Advisors sold 6,485 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2014, an estimated $696K.
  • Geneva Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 1 quarter.
  • Geneva Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $696K in Q2 2014.
  • 87 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2014.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.